跳至主要内容
临床试验/NCT03807973
NCT03807973
暂停
1 期

Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 120 人2021年10月5日

概览

阶段
1 期
干预措施
[Zr-89]Oxine-labeled leukocytes PET/MRI
疾病 / 适应症
Fibromyalgia
发起方
University of Alabama at Birmingham
入组人数
120
试验地点
2
主要终点
Regional brain distribution of radiolabeled white blood cells
状态
暂停
最后更新
2个月前

概览

简要总结

This study will use brain Positron Emission Tomography/ Magnetic Resonance Imaging (PET/MRI) and an investigational radioactive drug called [Zr-89]oxine to track the location of white blood cells (also called leukocytes) in the body. PET/MRI will be used to visualize labeled white blood cells and determine if they enter the central nervous system in conditions associated with brain inflammation (also called neuroinflammation). By better understanding the role of neuroinflammation in fibromyalgia, chronic fatigue syndrome, and multiple sclerosis, the investigator hopes to be able to better diagnose and treat patients in the future.

注册库
clinicaltrials.gov
开始日期
2021年10月5日
结束日期
2028年10月1日
最后更新
2个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Jonathan E McConathy

MD, PhD, Director for the Division Molecular Imaging and Therapeutics

University of Alabama at Birmingham

入排标准

入选标准

  • 1.18 to 65 years of age 2.Healthy volunteer OR
  • Clinical diagnosis of Multiple Sclerosis (MS) OR
  • Meets 2016 American College of Rheumatology (ACR) case definition criteria for fibromyalgia OR
  • Meets 1994 Fukuda case definition criteria for Chronic Fatigue Syndrome

排除标准

  • Contraindication to MRI
  • Individuals who are unable to participate in the imaging portion due to severity of their medical condition
  • Chronic infectious disease (e.g. HIV, HCV)
  • Viral or bacterial illness requiring medical attention and/or antibiotics within 1 month of study participation
  • Diagnosis of cancer, including leukemia
  • Blood or blood clotting disorder
  • Except for individuals with MS, a diagnosis of autoimmune disease is exclusionary
  • Positive urine pregnancy test day of procedure or a serum pregnancy test within 48 hours prior to the administration of Zirconium-89 Oxinate-4-labeled leukocytes
  • Currently enrolled in a clinical trial utilizing experimental therapies
  • Contraindication to gadolinium based contrast agents

研究组 & 干预措施

Fibromyalgia

干预措施: [Zr-89]Oxine-labeled leukocytes PET/MRI

Chronic Fatigue Syndrome

干预措施: [Zr-89]Oxine-labeled leukocytes PET/MRI

Multiple Sclerosis

干预措施: [Zr-89]Oxine-labeled leukocytes PET/MRI

Healthy Controls

干预措施: [Zr-89]Oxine-labeled leukocytes PET/MRI

结局指标

主要结局

Regional brain distribution of radiolabeled white blood cells

时间窗: 3 years

Descriptive statistics (means and standard deviations) of standardized uptake values (SUVs) will be presented for the patient groups and healthy controls in the following regions: whole brain, gray matter, white matter, atlas-based regions of interest, and lesions (MS patients only). Normality of the SUV distribution will be tested using Shapiro-Wilk tests, and the data will be transformed to normal distribution if necessary.

研究点 (2)

Loading locations...

相似试验